These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 7532929

  • 1. Significance of the tumour markers CA 125 II, CA 72-4, CASA and CYFRA 21-1 in ovarian carcinoma.
    Hasholzner U, Baumgartner L, Stieber P, Meier W, Hofmann K, Fateh-Moghadam A.
    Anticancer Res; 1994; 14(6B):2743-6. PubMed ID: 7532929
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Tissue polypeptide specific antigen and cancer associated serum antigen in the follow-up of ovarian cancer.
    Sliutz G, Tempfer C, Kainz C, Mustafa G, Gitsch G, Koelbl H, Biegelmayer C.
    Anticancer Res; 1995; 15(3):1127-9. PubMed ID: 7645936
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A multicentre evaluation of tumour marker determinations using the automatic Enzymun-Test Systems ES 300 and ES 600/700.
    van Dalen A, Kessler AC.
    Eur J Clin Chem Clin Biochem; 1996 Apr; 34(4):377-84. PubMed ID: 8704058
    [Abstract] [Full Text] [Related]

  • 9. Tumor-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA125) in patients with epithelial ovarian cancer.
    Peters-Engl C, Medl M, Ogris E, Leodolter S.
    Anticancer Res; 1995 Apr; 15(6B):2727-30. PubMed ID: 8669854
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Significance of CA 125 serum level in discrimination between benign and malignant masses in the pelvis.
    Milojkovic M, Hrgovic Z, Hrgovic I, Jonat W, Maass N, Buković D.
    Arch Gynecol Obstet; 2004 Mar; 269(3):176-80. PubMed ID: 14557888
    [Abstract] [Full Text] [Related]

  • 13. CYFRA 21-1 in non-small cell lung cancer--standardisation and application during diagnosis.
    Pavićević R, Bubanović G, Franjević A, Stancić-Rokotov D, Samarzija M.
    Coll Antropol; 2008 Jun; 32(2):485-98. PubMed ID: 18756899
    [Abstract] [Full Text] [Related]

  • 14. [The CA-125 tumor marker in epithelial ovarian cancers of stage I].
    Nagele F, Vavra N, Kurz C, Sevelda P.
    Wien Klin Wochenschr; 1993 Jun; 105(20):585-8. PubMed ID: 8259686
    [Abstract] [Full Text] [Related]

  • 15. TPS and CA 125 levels in serum, cyst fluid and ascites of patients with epithelial ovarian neoplasms.
    Harłozinska A, Sedlaczek P, Van Dalen A, Rozdolski K, Einarsson R.
    Anticancer Res; 1997 Jun; 17(6D):4473-8. PubMed ID: 9494553
    [Abstract] [Full Text] [Related]

  • 16. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
    Koelbl H, Schieder K, Neunteufel W, Bieglmayer C.
    Neoplasma; 1989 Jun; 36(4):473-8. PubMed ID: 2770933
    [Abstract] [Full Text] [Related]

  • 17. [Studies on clinical usefulness of new tumor markers of ovarian cancer, CA54/61 and CA602--III. Measurement of serum samples from patients with various benign or malignant diseases].
    Nozawa S, Udagawa Y, Sasaki H, Ito K, Akiya K, Terashima Y, Takamizawa H, Ohkura H, Fujimoto S, Hashimoto M.
    Gan To Kagaku Ryoho; 1994 May; 21(6):823-32. PubMed ID: 8185340
    [Abstract] [Full Text] [Related]

  • 18. CA 195: a new monoclonal antibody-defined Lea blood group-related tumor marker in patients with epithelial ovarian cancer.
    Gadducci A, Ferdeghini M, Prontera C, Moretti L, Pellagatta L, Bianchi R, Fioretti P.
    J Nucl Biol Med (1991); 1991 May; 35(1):33-7. PubMed ID: 1657201
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.